Networking for rare diseases: a necessity for Europe

@article{Aym2007NetworkingFR,
  title={Networking for rare diseases: a necessity for Europe},
  author={S{\'e}gol{\`e}ne Aym{\'e} and J{\"o}rg Schmidtke},
  journal={Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz},
  year={2007},
  volume={50},
  pages={1477-1483}
}
  • S. Aymé, J. Schmidtke
  • Published 19 November 2007
  • Medicine
  • Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Most rare diseases are life-threatening and chronically debilitating conditions, and the vast majority of them are genetically determined. Their individually low prevalence requires special combined efforts to address them so as to improve diagnosis, care and prevention. Though it is difficult to develop a public health policy specific to each rare disease, it is possible to have a global rather than a piecemeal approach in the areas of scientific and biomedical research, drug research and… 
EUNEFRON, the European Network for the Study of Orphan Nephropathies.
  • O. Devuyst, I. Meij, W. V. van’t Hoff
  • Medicine
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2009
TLDR
The EUNEFRON consortium is a consortium that has been mobilized in response to the Call HEALTH-2007-2.4.4-1 (‘Natural course and pathophysiology of rare diseases principally affecting the genitourinary tract’) of the framework 7 (FP7) programme for health of the European Union.
Care for patients with ultra-rare disorders.
  • R. Hennekam
  • Medicine
    European journal of medical genetics
  • 2011
Gathering and Managing Genotype and Phenotype Information about Rare Diseases Patients
TLDR
The aim of this project was to build a Web information system to support practice and clinical research in rare diseases, and to facilitate the collection of scientific information, diagnosis, treatment and patient support.
Diagnostic needs for rare diseases and shared prediagnostic phenomena: Results of a German-wide expert Delphi survey
TLDR
There is need for improving the diagnostic process in individuals with rare diseases, and shared experiences in Individuals with a rare disease were observed, which could possibly be utilized for diagnostic support in the future.
The HemoRec Database as an Example of a Rare Diseases Registry
TLDR
The HemoRec database, implemented in 2006 in six European countries, is presented as an example of an international registry of inherited bleeding disorders and can be developed in the future into a national platform of data collection and exchange in the network of Polish, and hopefully also European, haemophilia treatment centres.
Representation of Patients With Rare Diseases in Spanish Media
TLDR
The findings highlight the effort that has been made by patient advocacy groups with rare diseases and their relatives and caregivers, who have been recognized and proactive to get the treatment and medication needed.
Targeted therapy in rare cancers—adopting the orphans
TLDR
Drug-class examples of targeted therapies for orphan diseases, with particular emphasis on malignancies or tumour-prone nonmalignant conditions, are described, as well as potential therapeutic strategies that can be adopted to treat these orphan conditions.
On rare and "super-rare" diseases: an insight from the Republic of Macedonia.
Rare diseases (RD) are becoming increasingly important as possible targets of new forms of treatment, as a valuable source of a novel insight in fundamental lows of biology, and in the specific
THE ROLE OF THE ICT IN PROCESS MONITORING AND SYSTEM IMPACT ASSESSMENT OF RARE DISEASE COLLABORATIVE NETWORKS
TLDR
The project results can be used as input for the definition of the organizational model and of the information system of the new Italian network of rare tumours (Rete Nazionale Tumori Rari) and to strengthen Italy within the European Reference Networks on Rare Adult Cancers (ERNs-EURACAN).
Rare diseases: Challenges and resources
TLDR
Scientists have found that rare diseases are usually genetic and chronic, making it a challenge to develop drugs and medical devices that prevent, diagnose, and treat these diseases.
...
...

References

SHOWING 1-3 OF 3 REFERENCES
[Use of a directory of specialized services and guidance in the healthcare system: the example of the Orphanet database for rare diseases].
TLDR
The Orphanet directory is used to refer patients and specimens, especially by experts and patient organizations, and appears to have more impact on referrals within the healthcare system for laboratories than for specialized outpatient clinics.
Rare disease research gets boost.